Baseline characteristics from evoke and evoke+: Two phase 3 randomized placebo-controlled trials of semaglutide in participants with early-stage symptomatic Alzheimer's disease
来自 evoke 和 evoke+ 的基线特征：两项针对早期症状性阿尔茨海默病患者的索玛鲁肽 3 期随机安慰剂对照试验
期刊:Alzheimer's and Dementia: Translational Research and Clinical Interventions
影响因子:6.8
doi:10.1002/trc2.70200
Scheltens, Philip; Atri, Alireza; Feldman, Howard H; Zetterberg, Henrik; Sano, Mary; Johannsen, Peter; Colombo, Teresa León; Bardtrum, Lars; Jeppesen, Rose; Hansen, Charlotte T; Cummings, Jeffrey L
